These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23253752)

  • 1. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
    Horberg M; Raymond B
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV pre-exposure prophylaxis.
    Morin SF; Yamey G; Rutherford GW
    BMJ; 2012 Aug; 345():e5412. PubMed ID: 22890030
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS research. Complexity surrounds HIV prevention advances.
    Cohen J
    Science; 2011 Jul; 333(6041):393. PubMed ID: 21778370
    [No Abstract]   [Full Text] [Related]  

  • 4. CDC launches prevention efforts focused on PrEP, high-risk groups.
    AIDS Policy Law; 2015 May; 30(6):1, 4. PubMed ID: 26117851
    [No Abstract]   [Full Text] [Related]  

  • 5. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
    Coutinho B; Prasad R
    Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
    Curran JW; Crosby RA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S163-6. PubMed ID: 23253761
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-exposure prophylaxis for HIV: can it be implemented in the real world?
    Katz MH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S161-2. PubMed ID: 23253760
    [No Abstract]   [Full Text] [Related]  

  • 8. From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
    Warren MJ; Bass ES
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S167-70. PubMed ID: 23253762
    [No Abstract]   [Full Text] [Related]  

  • 9. Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.
    Tilson HH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S151-5. PubMed ID: 23253758
    [No Abstract]   [Full Text] [Related]  

  • 10. CDC promotes pre-exposure prophylaxis for HIV prevention.
    Roehr B
    BMJ; 2014 May; 348():g3384. PubMed ID: 24841703
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention. Using PrEP cost-effective in high-risk MSM groups.
    AIDS Policy Law; 2012 Jun; 27(7):1. PubMed ID: 22803211
    [No Abstract]   [Full Text] [Related]  

  • 12. Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis.
    Expert Rev Clin Immunol; 2010 Mar; 6(2):186. PubMed ID: 20402380
    [No Abstract]   [Full Text] [Related]  

  • 13. Mexico conference considers pre-exposure prophylaxis for AIDS.
    Roehr B
    BMJ; 2008 Aug; 337():a1278. PubMed ID: 18703652
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical challenges of preexposure prophylaxis for HIV.
    Jay JS; Gostin LO
    JAMA; 2012 Sep; 308(9):867-8. PubMed ID: 22847147
    [No Abstract]   [Full Text] [Related]  

  • 15. More pre-exposure prophylaxis for rising HIV infection?
    Barreiro P
    AIDS Rev; 2014; 16(2):118-9. PubMed ID: 24984768
    [No Abstract]   [Full Text] [Related]  

  • 16. The new revolution: HIV prevention in a pill.
    Grant R
    Posit Aware; 2013; 25(5):2-5. PubMed ID: 25358197
    [No Abstract]   [Full Text] [Related]  

  • 17. PrEP trial in women halted due to doubts that it could show efficacy.
    McEnery R
    IAVI Rep; 2011; 15(2):21. PubMed ID: 21608329
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
    Cohen J
    Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
    [No Abstract]   [Full Text] [Related]  

  • 19. A combination drug for HIV prevention in high-risk groups.
    Wallis L
    Am J Nurs; 2014 Aug; 114(8):15. PubMed ID: 25075683
    [No Abstract]   [Full Text] [Related]  

  • 20. From professional to personal.
    Johnson AD
    Posit Aware; 2013; 25(5):6-7. PubMed ID: 25358198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.